# Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease

> **NCT04926272** · PHASE2 · UNKNOWN · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** 18F-92

## Key facts

- **NCT ID:** NCT04926272
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04926272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04926272, "Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04926272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*